VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,987,000 | +69.3% | 142,832 | +113.0% | 0.13% | +641.2% |
| Q1 2016 | $1,764,000 | -73.5% | 67,054 | +2.6% | 0.02% | -72.6% |
| Q4 2015 | $6,647,000 | +0.7% | 65,386 | +76.6% | 0.06% | -23.5% |
| Q3 2015 | $6,604,000 | -77.5% | 37,021 | -72.0% | 0.08% | -78.9% |
| Q2 2015 | $29,379,000 | +2855.6% | 132,247 | +2541.8% | 0.38% | +2846.2% |
| Q1 2015 | $994,000 | -93.7% | 5,006 | -95.5% | 0.01% | -93.8% |
| Q4 2014 | $15,870,000 | +127.1% | 110,894 | +108.2% | 0.21% | +107.9% |
| Q3 2014 | $6,987,000 | +747.9% | 53,256 | +751.6% | 0.10% | +573.3% |
| Q1 2014 | $824,000 | – | 6,254 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |